FDA AWOL on BPA

Related articles

The Milwaukee Journal Sentinel reports: "Despite months of additional study and a self-imposed timetable, the U.S. Food and Drug Administration likely will not release its ruling Monday on the safety of bisphenol-A."

"The FDA said it would rule on BPA in November, but it doesn't look like that's going to happen," says ACSH's Dr. Elizabeth Whelan. "Of course, the FDA has in previous instances already reviewed BPA extensively and concluded that it doesn't pose a health risk. It's interesting that this showed up in the Sentinel, since they have been on a crusade against BPA for some time."

"They are being fed data by folks at EWG, NRDC, and other so-called 'environmental' groups in order to publicize the activist point of view on the low-dose phenomenon," says ACSH's Dr. Gilbert Ross. "No scientific body that has reviewed BPA and there have been many has ruled that it poses a health risk to human beings at environmental exposures."

For more information, see ACSH's publication on BPA.